1/ Dr Clare Craig explains why the FDA should NOT have granted approval for roll-out in the 6 month to 4 yr old children cohort
This trial should have been deemed null and void. The regulators are failing to do their job.
Share widely & follow
@hartgroup_org for updates
2/ Part 2 It should be noted, the FDA voted unanimously to approve the drug for this age group. Given the problems outlined, this is unbelievable. Follow
@hartgroup_org for further updates. Please share widely